We are international
Donate
TEXT SIZE   


ASH 2012: Dr. Siegel - A Phase 2 Study of Prolonged Carfilzomib Therapy in Patients with Multiple Myeloma Previously Enrolled in Carfilzomib Clinical Trials
David Siegel, MD, PhD
John Theurer Cancer Center at Hackensack University Medical Center
Hackensack, NJ
12.19.12


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles